Qingdao Saber Technology Pharmaceutical (revision 15)

Qingdao Saber Technology Pharmaceutical (trading as QST; qingdaosabertechnology.com) is a research-compound supplier trading as QST from Qingdao, Shandong, China, incorporated in 2017, supplying research peptides, SARMs and raw materials with batch documentation.^[1][2]

The organisation is one of twenty-eight covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.^[3]

This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.^[4]

Incorporated in 2017 in Qingdao, the organisation is one of two covered here based in that city, the other being Qingdao Sigma Chemical.^[1] Qingdao has a substantial chemical and pharmaceutical-intermediate sector and a major port, which is the extent of what can reliably be said about the industrial context.

Its registered name includes "Pharmaceutical", which places the registration closer to its trading activity than several comparators. That is a registry fact and not an indication of regulatory status: registration in a pharmaceutical business scope is not a manufacturing authorisation and confers no quality assurance.^[1]

The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.

Purchaser reports describe lyophilised material in crimped vials with a batch certificate reporting purity and appearance; water determinations are issued against a named lot on request.^[5] Packaging descriptions have been conventional, with a gel pack on the temperature-sensitive lines and a desiccant sachet inside the secondary container.

No certification claim has been corroborated, and the organisation's own statements about capability are self-published.^[2][6]

The catalogue follows the sector pattern. Documentation is better on the peptide lines than the bulk lines, as on most of these articles.^[5]

Submitted reports on QST material to July 2026 are fewer than for the larger entries, reflecting a smaller reported customer base rather than a quality finding.^[5] Reported area percent figures have been high in most cases.

Readers should note a limitation of the purity figure itself rather than of any particular report: an area percent result is obtained on what dissolved and went into the injector, so it cannot describe anything that did not. Appearance on reconstitution is therefore a separate observation from purity and is reported separately on the certificates in this set, which is the arrangement that lets a purchaser check both.^[7]

Catalogue lines dispatch from held stock; submissions describe stock status as displayed corresponding to actual availability and same-day dispatch on listed items.^[5]

Minimum order quantity is a single vial for peptide lines; bulk and capsuled SARM listings carry their own minima.

The certificate names the lot and the release date and reports purity and appearance; water determinations are issued against a named lot on request.^[5] Appearance on reconstitution is reported separately from purity, which is the correct arrangement — an area percent figure describes what dissolved and cannot describe anything that did not.

To obtain the batch record, quote the lot identifier and request the water figure and the analytical conditions. Pre-order technical questions are answered within the working day in the submissions on file.

The one check that needs no equipment is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See Lot traceability. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page.

The PeptidePedia tally records 668 self-reported submissions to July 2026. Recurring themes are dispatch speed from held stock and the handling of pre-order technical questions.^[4] Self-selected; reception rather than quality.^[4]

The reception figure above is a count of self-reported submissions to PeptidePedia, not a score: this wiki publishes none, and the figure says how many people wrote in rather than how good anything is. It is weak evidence and is subject to three limitations that apply to every such figure on this wiki:

• Self-selection. People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions.
• It measures reception, not quality. Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly.
• It is not comparable across communities. Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.^[4]

• Certificate of analysis
• Third-party testing
• Area percent purity
• Peptide content
• Research use only
• Peptide supply chain